Savino Sciascia Selected Research

Autoantibodies

4/2021	Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy.
10/2020	Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome.
1/2019	Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.
9/2014	Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.
2/2014	Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
6/2013	Management of infection in systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Savino Sciascia Research Topics

Disease

53	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2022 - 12/2011
27	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022 - 08/2012
27	Thrombosis (Thrombus) 10/2021 - 06/2011
11	Vasculitis (Vasculitides) 03/2022 - 01/2011
11	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 06/2013
9	Proteinuria 01/2022 - 01/2011
9	Infections 01/2022 - 01/2013
8	Glomerulonephritis 01/2022 - 12/2015
7	Inflammation (Inflammations) 03/2022 - 02/2010
7	Hypertension (High Blood Pressure) 12/2019 - 06/2011
6	Lupus Nephritis 05/2022 - 01/2015
6	COVID-19 01/2022 - 05/2020
5	Rheumatoid Arthritis 01/2022 - 08/2015
5	Venous Thrombosis (Deep-Vein Thrombosis) 12/2020 - 02/2013
4	Neoplasms (Cancer) 01/2021 - 03/2016
4	Immunoglobulin Light-chain Amyloidosis 01/2021 - 06/2020
3	Cryoglobulinemia 01/2022 - 01/2016
3	Renal Insufficiency (Renal Failure) 01/2022 - 03/2012
3	Arthritis (Polyarthritis) 12/2021 - 12/2011
3	Giant Cell Arteritis (Horton Disease) 03/2021 - 09/2011
3	Osteonecrosis (Kienbock's Disease) 01/2021 - 01/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2020 - 10/2017
2	Wounds and Injuries (Trauma) 01/2022 - 08/2020
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 06/2018
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 08/2017
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 03/2012
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022 - 04/2021
2	Pain (Aches) 08/2021 - 09/2020
2	Ulcer 01/2021 - 09/2020
2	Spontaneous Abortion (Miscarriage) 01/2021 - 01/2020
2	Thrombocytopenia (Thrombopenia) 01/2021 - 02/2019
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 03/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 02/2017
2	Pregnancy Complications 11/2020 - 12/2017
2	Venous Thromboembolism 07/2020 - 06/2015
2	Chronic Renal Insufficiency 03/2020 - 12/2017
2	Nephritis 03/2020 - 12/2011
2	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2019 - 06/2018
2	Pemphigus (Pemphigus Vulgaris) 05/2019 - 05/2018
2	Hemorrhage 12/2017 - 01/2015
2	Churg-Strauss Syndrome (Allergic Angiitis) 08/2017 - 01/2011
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2017 - 01/2011
2	Microscopic Polyangiitis 08/2017 - 01/2011
1	Takayasu Arteritis (Arteritis, Takayasu's) 11/2022
1	Gout 01/2022
1	Acute Tubulointerstitial Nephritis 01/2022

Drug/Important Bio-Agent (IBA)

45	Antiphospholipid AntibodiesIBA 09/2022 - 01/2009
30	AntibodiesIBA 01/2022 - 02/2013
16	Rituximab (Mabthera)FDA Link 01/2022 - 01/2011
12	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021 - 06/2011
9	Prothrombin (Factor II)IBA 01/2021 - 02/2013
8	Immunoglobulin G (IgG)IBA 04/2021 - 02/2013
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2011
7	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2016
7	CreatinineIBA 04/2021 - 01/2011
7	PhosphatidylserinesIBA 01/2021 - 02/2013
7	Anticardiolipin AntibodiesIBA 01/2021 - 11/2015
7	Glycoproteins (Glycoprotein)IBA 10/2020 - 01/2015
6	AutoantibodiesIBA 04/2021 - 06/2013
6	SteroidsIBA 11/2018 - 01/2011
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2022 - 01/2011
5	GlucocorticoidsIBA 01/2022 - 06/2012
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2011
5	Immunoglobulin M (IgM)IBA 04/2021 - 02/2013
5	Biological ProductsIBA 03/2021 - 08/2013
4	Monoclonal AntibodiesIBA 01/2022 - 06/2017
4	Vitamin K FDA Link 06/2020 - 10/2016
3	tocilizumab (atlizumab)FDA Link 11/2022 - 05/2020
3	Complement System Proteins (Complement)IBA 03/2022 - 05/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 11/2018
3	Methylprednisolone FDA LinkGeneric 01/2022 - 12/2011
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2018
3	Phospholipids (Phosphatides)FDA LinkGeneric 03/2021 - 02/2017
3	MicroRNAs (MicroRNA)IBA 04/2020 - 10/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 03/2012
2	TinIBA 01/2022 - 12/2020
2	Antimalarials (Antimalarial Agents)IBA 01/2022 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	belimumabIBA 01/2022 - 11/2018
2	Colchicine FDA LinkGeneric 01/2022 - 09/2020
2	tofacitinibIBA 01/2022 - 01/2020
2	anti-dsDNA autoantibodyIBA 01/2021 - 12/2015
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 12/2017
2	daratumumabIBA 10/2020 - 09/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2018 - 06/2017
2	AnticoagulantsIBA 12/2017 - 10/2016
2	Biosimilar PharmaceuticalsIBA 02/2017 - 08/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015 - 01/2014
2	APTIBA 02/2014 - 02/2013
2	C-Reactive ProteinIBA 08/2012 - 01/2011
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2012 - 03/2012
1	AS 8IBA 09/2022
1	VaccinesIBA 04/2022
1	InterleukinsIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022

Therapy/Procedure

30	Therapeutics 01/2022 - 01/2011
3	Biological Therapy 02/2017 - 08/2015
2	Drug Therapy (Chemotherapy) 10/2020 - 01/2017
2	Oral Medicine 09/2020 - 05/2019
2	Radiotherapy 01/2017 - 03/2016